Follow Chr. Hansen A/S

Press releases 2 hits

Chr. Hansen in joint venture to accelerate momentum in microbiome

Chr. Hansen in joint venture to accelerate momentum in microbiome

Press releases   •   Apr 02, 2019 15:31 UTC

Chr. Hansen in joint venture to accelerate momentum in microbiome Danish bioscience company, Chr. Hansen, joins forces with Lonza AG to pioneer the emerging market for live biotherapeutic products

Chr. Hansen enters first collaboration on production of a next generation probiotic from the Human Microbiome

Chr. Hansen enters first collaboration on production of a next generation probiotic from the Human Microbiome

Press releases   •   Jan 14, 2016 07:08 UTC

Today, Chr. Hansen and Caelus Health announce their collaboration on the development of Eubacterium hallii as a next generation probiotic for prevention and treatment of metabolic disease.

News 1 hit

Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products

Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products

News   •   Aug 29, 2019 09:16 UTC

​Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading pharma contract manufacturing company, announce today that they have received the relevant approvals from anti-trust regulators needed to establish the 50/50 joint venture in the emerging market for live biotherapeutic products, which was originally announced in Company Announcement No. 04 on April 2, 2019.